We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CURV icon
501
Torrid Holdings
CURV
$260M
$36.8K 0.02%
12,463
-14,433
-54% -$75.6K
SRG
502
Seritage Growth Properties
SRG
$136M
$31.7K 0.01%
10,300
-2,808
-21% -$8.09K
CVGI icon
503
Commercial Vehicle Group
CVGI
$147M
$19.3K 0.01%
11,632
-8,513
-42% -$10.3K
AAL icon
504
American Airlines Group
AAL
$10.6B
– –
-23,116
Closed -$244K
ACEL icon
505
Accel Entertainment
ACEL
$987M
– –
-12,794
Closed -$127K
ACMR icon
506
ACM Research
ACMR
$5.79B
– –
-12,061
Closed -$282K
AEO icon
507
American Eagle Outfitters
AEO
$3.01B
– –
-19,563
Closed -$227K
AFCG
508
AFC Gamma
AFCG
$63.4M
– –
-10,089
Closed -$56.2K
AFRM icon
509
Affirm
AFRM
$25.2B
– –
-8,266
Closed -$374K
AGX icon
510
Argan
AGX
$8.37B
– –
-2,411
Closed -$316K
AIG icon
511
American International
AIG
$41.3B
– –
-9,493
Closed -$825K
ALEX
512
DELISTED
Alexander & Baldwin
ALEX
– –
-10,876
Closed -$187K
ALGN icon
513
Align Technology
ALGN
$12.3B
– –
-2,448
Closed -$389K
ALGT icon
514
Allegiant Air
ALGT
$2.57B
– –
-3,940
Closed -$204K
AMAT icon
515
Applied Materials
AMAT
$428B
– –
-5,230
Closed -$759K
AMRC icon
516
Ameresco
AMRC
$1.36B
– –
-14,705
Closed -$178K
AMT icon
517
American Tower
AMT
$80.4B
– –
-2,396
Closed -$521K
AON icon
518
Aon
AON
$76B
– –
-1,129
Closed -$451K
ARQT icon
519
Arcutis Biotherapeutics
ARQT
$3.18B
– –
-11,049
Closed -$173K
ASC icon
520
Ardmore Shipping
ASC
$683M
– –
-17,291
Closed -$169K
ASPN icon
521
Aspen Aerogels
ASPN
$518M
– –
-22,397
Closed -$143K
ATEC icon
522
Alphatec Holdings
ATEC
$1.44B
– –
-14,118
Closed -$143K
ATRO icon
523
Astronics
ATRO
$3.84B
– –
-21,437
Closed -$432K
AVD icon
524
American Vanguard Corp
AVD
$68.9M
– –
-15,259
Closed -$67.1K
AVO icon
525
Mission Produce
AVO
$1.17B
– –
-20,025
Closed -$210K
19 20
21
22 23

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.